Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional-dose versus full-dose IPV in Cuban infants
ACTRN12610001046099Phase 2Active, not recruiting
- Sponsor
- World Health Organization
- Start
- Jul 2009
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of trivalent inactivated polio vaccine and trivalent oral poliovirus vaccine in poliomyelitis (2 arms), sponsored by World Health Organization. Primary endpoints: Seroconversion by neutralization assay after 2 IPV doses, Seroconversion after first dose, priming after first dose, and seroconversion after second dose and 1 more. Started Jul 2009; status: active, not recruiting.
02
Drugs
trivalent inactivated polio vaccinetrivalent oral poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on ACTRN12610001046099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610001046099.